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A B S T R A C T
The present study examines the susceptibility of mouse induced pluripotent stem cell-derived neural precursor
cells (iPSC-NPCs) to infection with the neurotropic JHM strain of mouse hepatitis virus (JHMV). Similar to
NPCs derived from striatum of day 1 postnatal GFP-transgenic mice (GFP-NPCs), iPSC-derived NPCs (iPSC-
NPCs) are able to diﬀerentiate into terminal neural cell types and express MHC class I and II in response to
IFN-γ treatment. However, in contrast to postnatally-derived NPCs, iPSC-NPCs express low levels of
carcinoembryonic antigen-cell adhesion molecule 1a (CEACAM1a), the surface receptor for JHMV, and are
less susceptible to infection and virus-induced cytopathic eﬀects. The relevance of this in terms of therapeutic
application of NPCs resistant to viral infection is discussed.
1. Introduction
Neural precursor cell (NPC) transplantation represents an emer-
ging therapeutic approach to treat several neurological disorders.
NPC transplants into rodent models of Alzheimer's disease,
Parkinson's disease and spinal cord injury have demonstrated
clinical beneﬁts (Blurton-Jones et al., 2009; Cummings et al.,
2005; van Gorp et al., 2013). Further, NPCs have been suggested
as a potential treatment for the neuroinﬂammatory autoimmune
demyelinating disease multiple sclerosis (MS) as they represent
attractive sources for the generation of myelin-competent oligoden-
drocytes (Ben-Hur et al., 1998; Brustle et al., 1999). NPC-derived
glial progenitors have been shown to remyelinate axons following
transplantation into regions of acute experimental demyelination
(Ben-Hur et al., 1998; Keirstead et al., 1999). In addition, trans-
plantation of neural precursors into a rodent autoimmune model of
demyelination resulted in migration of transplanted cells into white
matter tracts accompanied by an improvement in clinical outcome
(Ben-Hur et al., 2003; Pluchino et al., 2003). In these pre-clinical
autoimmune models of MS, NPCs have been suggested to act as
modulators of the immune system or directly replace damaged or
lost endogenous NPCs that subsequently allows for dampening
disease progression, axonal preservation and remyelination
(Aharonowiz et al., 2008; Pluchino et al., 2009, 2003).
An important and clinically relevant question is whether trans-
planted NPCs can alleviate demyelination caused by persistent viral
infection. Although the cause of MS has been attributed to multiple
factors, viruses have long been considered as a potential triggering
agent for MS in genetically susceptible individuals (Gilden, 2005; Olson
et al., 2005). Therefore, it is important to study the remyelination
potential of NPCs in the context of virally-induced neurologic disease,
as this will give important insights into whether cell replacement
therapies are eﬀective within the CNS where neurotropic viruses may
be persistent. With this in mind, we have previously shown that
engraftment of postnatal-derived NPCs into the spinal cords of
JHMV-infected mice with established demyelinating disease resulted
in the selective colonization of demyelinating white matter tracts by
transplanted cells accompanied by remyelination and axonal sparing
(Carbajal et al., 2010, 2011; Totoiu et al., 2004; Greenberg et al., 2014).
In a clinical setting, NPCs derived from donor-speciﬁc iPSCs may be
preferable since these cells will retain the genetic background of the
donor and potentially bypass the need for immunosuppressive drugs
that leave the patient susceptible to opportunistic infections and tumor
formation.
There are several known neurotropic viruses that are capable of
infecting and replicating in both NPCs and NPC-derived cells (Chucair-
Elliott et al., 2014; Huang et al., 2014; Schaumburg et al., 2008). For
example, herpes simplex virus type 1 (HSV-1) infects NPCs resulting in
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diminished numbers leading to loss of neuroblasts upon diﬀerentiation
(Chucair-Elliott et al., 2014). NPCs are also susceptible to infection by
Enterovirus 71, which causes depletion of their numbers via viral-
induced lysis (Huang et al., 2014). In addition, hESC-derived oligo-
dendrocyte progenitor cells (OPCs) are highly susceptible to infection
by JC virus, the causative agent of progressive multifocal leukoence-
phalopathy (PML) (Schaumburg et al., 2008). Coxsackievirus, another
virus capable of infecting the CNS, also preferentially replicates in
NPCs causing cell death and leading to developmental defects (Ruller
et al., 2012). Most recently, Zika virus has been shown in culture to
infect human NPCs derived from induced pluripotent stem cells and is
linked to fetal abnormalities in pregnant woman exposed to the virus
(Tang et al., 2016), while the human coronavirus OC43 was linked to
acute disseminated encephalomyelitis within a SCID patient that
received a cord-blood transplantation (Morfopoulou et al., 2016).
Dampened immune surveillance resulting from treatment with im-
munosuppressive drugs can cause re-emergence of persistent neuro-
tropic viruses which have the ability to infect and diminish numbers of
transplanted cells, thus muting therapeutic beneﬁts. Collectively, these
ﬁndings suggest that susceptibility of NPCs to infection by neurotropic
viruses is clinically important and must be evaluated before consider-
ing NPCs as a viable cell replacement therapy for various neurological
disorders.
We have previously shown that postnatally-derived NPCs are
susceptible to infection by JHMV resulting in virus-induced cell death
(Plaisted et al., 2014). Herein we demonstrate that NPCs derived from
induced pluripotent stem cells (iPSCs) are functionally similar to
cortical NPCs isolated from post-natal transgenic GFP-C57BL/6 mice
as they possess tri-potent diﬀerentiation potential and can form
oligodendrocytes, neurons and astrocytes (Carbajal et al., 2010;
Greenberg et al., 2014). However, they diﬀer in their susceptibility to
infection by JHMV in that iPSC-derived NPCs (iPSC-NPCs) express low
levels of the viral receptor CEACAM1a, making them refractory to
infection and virus-induced cell death.
2. Results and discussion
2.1. NPCs generated from mouse induced pluripotent stem cells are
functionally similar to postnatal GFP-NPCs
Mouse iPSCs were generated by retroviral transduction of
Yamanaka factors (Oct3/4 Sox2, Klf4 and c-Myc) into C57BL/6
ﬁbroblasts using established protocols (Takahashi and Yamanaka,
2006). Mouse iPSCs were grown and diﬀerentiated into NPCs accord-
ing to the schematic outlined in Fig. 1A. Feeder-free iPSCs were
generated by supplementing cells with leukemia inhibitory factor
(LIF) and stained positive for the stem cell markers- Oct4 and Sox2
(Fig. 1B). iPSCs were diﬀerentiated into NPCs by addition of EGF
(epidermal growth factor) and bFGF (basic ﬁbroblast growth factor)
and were positive for neuronal stem cell markers such as Sox2
(Fig. 1Ci), Nestin (Fig. 1Cii), and Pax6 (Fig. 1Ciii) as assessed by
immunoﬂuorescence analysis. iPSC-NPCs were then diﬀerentiated for
6 days following withdrawal of EGF and bFGF. Similar to postnatal
GFP-NPCs (henceforth referred to as GFP-NPCs) (Carbajal et al.,
2010). iPSC-NPCs also terminally diﬀerentiated into oligodendrocytes
(Fig. 1Di), neurons (Fig. 1Dii) and astrocytes (Fig. 1Diii) (Fig. 1E).
These ﬁndings illustrate that iPSC-NPCs have similar diﬀerentiation
properties as compared to postnatal-derived GFP-NPCs.
2.2. Expression of MHC class I and II following exposure to JHMV
It has been previously shown that, under normal physiologic
conditions, MHC class I and II are undetectable on NPCs and IFN-γ
treatment can induce expression of MHC on these cells (Chen et al.,
2011; Plaisted et al., 2014; Weinger et al., 2012). We found there was
constitutive expression of MHC class I on iPSC-NPCs and exposure to
either JHMV or recombinant mouse IFN-γ (100 U/mL) did not
modulate expression levels (Fig. 2A, C). In addition, MHC class II
expression was undetectable on iPSC-NPCs exposed to either medium
or JHMV, yet treatment with IFN-γ dramatically increased expression
(Fig. 2B, D)
2.3. NPCs derived from mouse iPSCs express low levels of JMHV
receptor CEACAM1a
The primary receptor for JHMV is murine carcinoembryonic
antigen-related cell adhesion molecule 1 (CEACAM1) (Hirai et al.,
2010; Williams et al., 1991). There are two alleles for murine
CEACAM1: mCeacam1a and mCeacam1b and inbred strains of mice
such as C57BL/6 and Balb/c are homozygous for mCeacam1a and are
highly susceptible to infection by JHMV (Williams et al., 1991).
CEACAM1a is widely expressed in a variety of mouse tissue and can
be detected on the surface of epithelial cells lining the respiratory tract,
endothelial cells and also on hematopoietic cells (Hemmila et al.,
2004). We have recently shown that cultured NPCs derived from 1-day
old C57BL/6 mice express CEACAM1a as determined by CEACAM1
mRNA transcripts as well as surface protein expression (Plaisted et al.,
2014). In order to determine whether NPCs derived from iPSCs express
CEACAM1a similar to GFP-NPCs, cell surface expression of the
receptor was evaluated by staining NPCs with an anti-CEACAM1
antibody. GFP-NPCs and mixed splenocytes from C57BL/6 were used
as controls. Flow cytometry analysis revealed that iPSC-NPCs ex-
pressed low levels of surface expression of CEACAM1 compared to
GFP-NPCs (Fig. 3A, B). Furthermore, qPCR analysis of mRNA isolated
from cultured iPSC-NPCs revealed a signiﬁcant (p < 0.0001) reduction
in CEACAM1a transcripts compared to mRNA isolated from GFP-
NPCs or splenocyte controls (Fig. 3C). Collectively, we interpret these
ﬁndings to indicate iPSC-NPCs express proportionally less CEACAM1a
compared to GFP-NPCs.
2.4. NPCs derived from iPSCs are less susceptible to JHMV infection
and virus induced cell death
We next evaluated the susceptibility of NPCs to JHMV infection. In
order to do this, cultured iPSC-NPCs were infected with JHMV for 18 h
and ﬁxed 72 h post-infection (p.i.). Cells were then stained with either
an anti-Sox2 antibody (to conﬁrm NPC status) or an antibody speciﬁc
for the carboxyl terminus of JHMV nucleocapsid protein and imaged
by ﬂuorescence microscopy (Plaisted et al., 2014). Compared to GFP-
NPCs, iPSC-NPCs express low levels of JHMV nucleocapsid protein,
suggesting these cells are less susceptible to JHMV infection (Fig. 4A,
B). To determine if JHMV-infection of NPC cultures induced cell death,
lactate dehydrogenase (LDH) was measured in the supernatants of
GFP-NPC and iPSC-NPC cultures at 24, 48 and 72 h p.i. GFP-NPCs
cultures infected with JHMV revealed a signiﬁcant (p < 0.001) increase
in cell death compared to JHMV-infected iPSC-NPC cultures (Fig. 4C).
Congruent with reduced cell death, we detected lower viral titers within
the supernatants of JHMV-infected iPSC-NPCs at 24 (p < 0.05), 48 (p
< 0.001), and 72 (p < 0.05) hours p.i. compared to infected GFP-NPCs
(Fig. 4D).
This study provides a comparative analysis of ex vivo expanded
neural precursor cell populations with regard to their susceptibility to
infection by a neurotropic coronavirus. These studies demonstrates
that although iPSC-NPCs are functionally similar to postnatally-
derived NPCs in their ability to diﬀerentiate into oligodendrocytes,
astrocytes and neurons, they are unique with respect to susceptibility to
viral infection and expression of MHC class I on the cell surface. iPSC-
NPCs express low levels of the JHMV receptor CEACAM1a, providing
reduced susceptibility and limited replication. Furthermore, due to the
impaired ability of virus to enter these cells and replicate, the cells are
resistant to virus-induced cell death. Nonetheless, we demonstrate that
after 72 h following infection of iPSC-NPCs there is an increase in cell
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Fig. 1. Generation of mouse iPSC-NPCs. (A) Schematic outline depicting generation of miPSC-NPCs from mouse iPSCs. (B) Feeder-free media adapted miPSCs stained for OCT4 and
SOX2 imaged by ﬂuorescence microscopy. (C) miPSC-NPCs were stained for neural precursor markers-SOX2 (Ci), Nestin (Cii) and PAX6 (Ciii) and imaged by ﬂuorescence microscopy.
(D) 6 days post diﬀerentiation, NPCs express markers for oligodendrocytes (OLIG2) (Di), neurons (MAP2) (Dii) and astrocytes (GFAP) (Diii) as determined by immunoﬂuorescent
staining; representative images are shown. (E) Quantiﬁcation of expression of lineage-speciﬁc markers, data shown as average + SEM.
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death yet viral titers remain relatively low. These ﬁndings argue that
iPSC-NPCs may be susceptible to JHMV-induced death over time due
to mechanism(s) as of yet undeﬁned and this is a focus of ongoing
investigation.
We have previously shown that intraspinal transplantation of postnatal
GFP-NPCs into JHMV-infected mice results in clinical recovery associated
with remyelination (Carbajal et al., 2011; Greenberg et al., 2014). However,
fetal-derived GFP-NPCs are susceptible to JHMV infection and undergo
virus-induced cell death in vitro (Plaisted et al., 2014). Additionally, when
engrafted into JHMV-infected mice, these cells are susceptible to infection
in vivo (Weinger et al., 2014). Within the context of myelinopathies, this
suggests that engrafting cells susceptible to persistent neurotropic viruses
may be ineﬀective, as viral infection could prevent them from surviving and
diﬀerentiating into myelin-producing oligodendrocytes. Since iPSC-NPCs
express low levels of the viral receptor and are resistant to virus-induced
cell death, they will presumably persist in vivo, providing increased
potential for oligodendrocyte diﬀerentiation and subsequent remyelination.
Ultimately, iPSC-NPCs may oﬀer a better cell-replacement option to
postnatal GFP-NPCs in the context of JHMV-mediated demyelination.
There are several neurotropic viruses that are known to persist in the
CNS that can preferentially infect and replicate in NPCs (Chucair-Elliott
et al., 2014; Huang et al., 2014; Ruller et al., 2012; Schaumburg et al.,
2008). In order to successfully employ NPCs for axon remyelination in the
damaged CNS, it is imperative to consider the possibility that transplanted
NPCs will be targeted by persistent CNS viruses. In a clinical setting, if
donor-derived human NPCs are used for treatment of MS or any other
neurological disease, the recipient will likely be under general immuno-
suppression drugs to prevent rejection of the engrafted MHC-mismatched
cells. However, systemic immunosuppression can lead to recrudescence of
dormant neurotropic viruses, typically kept in check by immune surveil-
lance. Consequently, engrafted NPCs may be targeted by reactivated
neurotropic viruses, which can infect and proliferate in NPCs, causing cell
death and diminishing therapeutic beneﬁt. Since iPSC-NPCs are ‘self-
derived’ and maintain the genetic background of the donor, they are
unlikely to be rejected by the host. iPSC-NPCs are functionally similar to
GFP-NPCs in their capacity to diﬀerentiate into remyelination-competent
oligodendrocytes, suggesting that they may be therapeutically similar to
engrafting GFP-NPCs. Indeed, a recent study showed that intraspinal
transplantation of NPCs derived from mouse iPSCs alleviates clinical and
pathological symptoms of experimental autoimmune encephalomyelitis
(Laterza et al., 2013). Our ﬁndings argue that engraftment of an NPC
population lacking speciﬁc receptors for known neurotropic viruses may
reduce the risk of infection and cytopathic eﬀects leading to more sustained
clinical recovery. Ongoing studies in our laboratory are currently testing this
hypothesis.
Fig. 2. Expression of MHC class I and II by iPSC-NPCs. iPSC-NPCs were either exposed to vehicle (mock infected) or JHMV (moi = 0.4) for 18 h. Cells were then treated with IFN-γ
(100U/mL) or media alone (no treatment, NT) for 24 h and surface expression of MHC class I and II expression analyzed by ﬂow cytometry. Representative dot blots depicting the
frequency of MHC class I (A) or class II (B) are shown. Quantiﬁcation of the frequency of MHC class I (C) and MHC class II (D) expression; data are presented as an average + SEM and
represents 3 independent experiments.
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3. Materials and methods
3.1. Virus
JHM strain of MHV (V34) was added to iPSC-NPCs or postnatal
GFP-NPCs expressing green ﬂuorescent protein (GFP-NPCs) at a
multiplicity of infection (m.o.i.) of 0. 4 PFU/cell. Following overnight
incubation (~18 h) media was replaced. Supernatants were collected at
deﬁned times post infection and viral titers were determined using the
DBT astrocytoma cell line as previously described (Hirano et al., 1976).
3.2. Neural precursor cell culture
GFP-NPCs were cultured as described before (Carbajal et al., 2011).
GFP-NPC media consisted of DMEM/F12 with Glutamax (Gibco),
ciproﬂoxacin hydrochloride (100 μg/mL, Cellgro), N2 supplement
(1X, Gibco), gentamycin(50 μg/mL, Sigma-Aldrich), fungizone
(2.5 μg/mL, Gibco), penicillin/streptomycin (1000 U/mL) and epider-
mal growth factor(20 ng/mL, Sigma-Aldrich). Feeder dependent iPSCs
were kindly provided by Dr. Kristin Baldwin (The Scripps Research
Institute). Feeder free iPSCs were generated by plating iPSCs in gelatin
coated ﬂasks and supplementing cells with leukemia inhibitory factor
(LIF). Feeder free-adapted iPSCs were then plated to generate embry-
oid bodies (EB). NPCs generated from iPSCs were cultured similar to
GFP-NPCs. Media used for culturing iPSC-NPCs consisted of DMEM/
F12 with Glutamax (Gibco), N2 supplement (1X, Gibco), penicillin/
Streptomycin (1000 U/mL), NEAA (100X, Gibco), epidermal growth
factor (20 ng/mL, Sigma-Aldrich) and fetal growth factor (20 ng/mL,
Millipore). Recombinant IFN-γ (100 U/mL) was purchased from Cell
Sciences.
3.3. Flow Cytometry analysis
NPCs were harvested using 0.05% Trypsin and suspended in PBS
containing 0.5% BSA. Subsequently, they were treated with antibodies
speciﬁc for CEACAM1a (APC conjugated, eBioscience), MHC class I
(APC conjugated, Biolegend) or MHC Class II (PE conjugated,
eBioscience) for 40 min. Detection of ﬂuorescence was performed
using LSR Fortessa X-20 (BD biosciences). FACS data was analyzed
using FlowJo software (Tree Star).
3.4. RNA isolation and quantitative Polymerase Chain Reaction
RNA was extracted from NPCs or splenocytes using the manufac-
turer's instructions using the RNeasy kit (Qiagen). cDNA was reverse
transcribed from RNA using SuperScript III First-Strand synthesis
system and random hexamers (Invitrogen). qPCR to detect CEACAM1a
transcripts was performed using the following primers:
TTCCCTGGGGAGGACTACTG (forward primer) and TGTATGC
TTGCCCCGTGAAAT (reverse primer) (DNA/ peptide synthesis facility,
HSC Cores at University of Utah). The amount of RNA added to every
sample was normalized by using β-actin as an internal control; the
relative expression of Ceacam1a was then calculated using the ΔΔCT
method (Livak and Schmittgen, 2001)
3.5. JHMV cytotoxicity assay
JHMV induced NPC cell death was evaluated at 24, 48 and 72 h p.i
by measuring the lactate dehydrogenase levels (LDH) using LDH
cytotoxicity assay (Promega). JHMV induced LDH levels were mea-
sured from infected NPCs and normalized to spontaneously released
LDH. The value was then expressed as a percentage of cell death due to
infection.
3.6. Immunoﬂuorescence
To determine JHMV infectivity of cultured NPCs, cells were plated
on reduced growth factor-matrigel (BD Biosciences) coated chamber
slides. NPCs were infected with JHMV (moi = 0. 4) for 18 h and
ﬁxed at 72 h p.i with 4% PFA for 20 min at room temperature.
Fig. 3. Surface CEACAM1a expression is reduced by iPSC-NPCs. (A) Representative dot blots showing surface expression of JHMV receptor-CEACAM1a on C57BL/6 splenocytes, GFP-
NPCs or iPSC-NPCs. (B) The mean ﬂuorescence intensity (MFI) of dot plots in (A) is quantiﬁed; data shown as average+SEM and represents two independent experiments. (C) Relative
expression levels of Ceacam1a (ΔΔCT) were measured by conducting qPCR on cDNA generated from total RNA extracted from C57BL/6 splenocytes or cultured GFP-NPCs and iPSC-
NPCs. β-actin was used as an internal control to normalize the amount of RNA. Data are derived from triplicate analysis and shown as average + SEM; ****p < 0.0001, ns = not
signiﬁcant.
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Immunoﬂuorescence was performed as described previously (Whitman
et al., 2009) using antibodies speciﬁc for rabbit monoclonal anti-Sox 2
(abcam, 1:100 dilution) or monoclonal antibody speciﬁc for JHMV
spike protein (Plaisted et al., 2014) and Alexa Flour 594 goat anti-
rabbit secondary antibody (Life technologies). Slides were then imaged
using a Nikon A1 inverted microscope.
3.7. Statistical analysis
Statistical analysis was carried out using student's t-test and p ≤
0.05 was considered signiﬁcant.
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